Mativ Holdings Inc

MATV remains in a Stage 4 decline with a clear downtrend across all timeframes, confirmed by lower highs and lower lows. Medium-term bias is bearish, but price is now extended below declining EMAs and in extreme oversold conditions. Execution will be deferred: trimming should occur on a relief bounce into resistance around the 8.4–8.9 zone, where EMAs and prior support-turned-resistance converge.

• ↑Q1 adjusted EBITDA of $47.5M (+28% YoY) marks strongest post-merger margin and cash flow performance.
• ↑Secured aerospace specialty films contract slated to ramp in Q2 2026, expanding into higher-growth markets.
• ↓Q1 net sales of $480M were down ~1% reported, flat organically, underscoring demand softness.